Dr. Reddy’s Laboratories a566h

No Picture
Business

Personalised medicine is a new thing fast gaining momentum: Deepak Sapra, CEO of Dr Reddy’s Laboratories 386r4j

Mansi Praharaj Comments Off on Personalised medicine is a new thing fast gaining momentum: Deepak Sapra, CEO of Dr Reddy’s Laboratories

Hyderabad, May 24, 2024….The Technology enables drug discovery faster, more efficiently and cheaper, said Mr Deepak Sapra, CEO of Dr. Reddy’s Laboratories while delivering an opening address at DXEM 2024–a day-long Summit on Navigating Digital […]

No Picture
Technology

Study: Digitalization Could Boost India’s GDP by USD1.04 Trillion by 2025 4sg2g

Mansi Praharaj Comments Off on Study: Digitalization Could Boost India’s GDP by USD1.04 Trillion by 2025

Hyderabad, May 23, 2024……A full-day Leadership Summit on Navigating Digital Transformation in Engineering and Manufacturing will be held in the city at HICC on Friday. Titled DXEM 24, it will be hosted by Plural Technology, […]

World

Dr. Reddy’s Laboratories announces appointment of new Chief Financial Officer 6k72p

team Comments Off on Dr. Reddy’s Laboratories announces appointment of new Chief Financial Officer

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that Parag Agarwal will be ing the Company as Chief Financial Officer (Designate) on November 2, 2020. The Board of Directors at their […]

Business

Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren(R) Arthritis Pain in the U.S. Market 6n405v

team Comments Off on Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren(R) Arthritis Pain in the U.S. Market

Hyderabad, India and Princeton, NJ, USA. September 9, 2020 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of […]

Business

Dr. Reddy’s Laboratories enters hospital nutrition segment with Celevida Maxx in India a6369

team Comments Off on Dr. Reddy’s Laboratories enters hospital nutrition segment with Celevida Maxx in India

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY), today announced the entry into the hospital nutrition segment with the launch of its nutrition drink, ‘Celevida Maxx’ in India. It is a unique […]

Health

Dr. Reddy’s Laboratories announces the launch of AVIGAN(R) (Favipiravir) in India 232b4b

team Comments Off on Dr. Reddy’s Laboratories announces the launch of AVIGAN(R) (Favipiravir) in India

Hyderabad, India, August 19, 2020 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of AVIGAN® (Favipiravir) 200 […]

No Picture
Business

Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Nicotine Polacrilex Lozenges, 2 mg and 4 mg, the store brand version of Nicorette® Lozenges in the U.S. Market 514l5s

team Comments Off on Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Nicotine Polacrilex Lozenges, 2 mg and 4 mg, the store brand version of Nicorette® Lozenges in the U.S. Market

Hyderabad, India and Princeton, NJ, USA. July 14, 2020 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch […]

Business

Dr. Reddy’s Laboratories announces the launch of an authorized generic version of NitroDur(R) (nitroglycerin) Transdermal Infusion System in the U.S. Market 66732u

Praveen Comments Off on Dr. Reddy’s Laboratories announces the launch of an authorized generic version of NitroDur(R) (nitroglycerin) Transdermal Infusion System in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of authorized generic version of NitroDur® (nitroglycerin) Transdermal Infusion System. The […]

Business

Dr. Reddy’s Laboratories announces the launch of Amphetamine Sulfate Tablets USP, in the U.S. Market 1q246m

Praveen Comments Off on Dr. Reddy’s Laboratories announces the launch of Amphetamine Sulfate Tablets USP, in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Amphetamine Sulfate Tablets USP, a therapeutic equivalent generic version of […]

Business

Dr. Reddy’s Laboratories announces the launch of Invista(R) (dasatinib) in India 1e35n

Praveen Comments Off on Dr. Reddy’s Laboratories announces the launch of Invista(R) (dasatinib) in India

Dr. Reddy’s Laboratories Ltd., today announced the launch of Invista®, a formulation of Dasatinib that is bioequivalent to the innovator brand. It is indicated for the treatment of chronic accelerated or myeloid or lymphoid blast […]